StockData
BioVie Inc. logo

BioVie Inc. (BIVI) stock

BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$0.94−0.05 (-5.27%)

Close on Nov 18, 2026Market cap $7.11MP/E –Yield –

BioVie price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for BioVie

BioVie has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More BioVie figures

See a number that looks wrong?